Sun Safety & Skin Cancer: Evidence and Prevention

THE TANRUB JOURNAL · SUN PROTECTION & RESEARCH

UV radiation damages skin even on cool days. The strongest protection combines clothing, sunscreen, hats, shade and sunglasses, with advice tailored to your skin and personal risk.

By Tanrub Editorial · Sources checked 17 October 2026

This article is an editorial summary of published research and Australian guidance, adapted from a supplied draft. It has not been medically reviewed and is not personal medical advice. See a doctor promptly about a new, changing, bleeding or non-healing skin lesion.

Key points

Excess UV exposure is a major preventable cause of skin cancer. Sunburn and deliberate UV tanning both add damage.
Use the UV Index, rather than temperature, to plan protection. The standard Australian public-health trigger is UV 3 or above; individual advice can differ with skin type and risk.
Choose SPF50 or SPF50+, broad-spectrum, water-resistant sunscreen and use it alongside clothing, hats, shade and sunglasses.
The Nambour trial found about 39% fewer squamous-cell tumours at application sites with daily sunscreen. Its melanoma follow-up was encouraging, but involved few cases.
Neither a suntan nor fake-tan colour replaces sun protection. UV-emitting sunbeds are carcinogenic.
Vitamin D needs and skin-check schedules should be assessed individually. Do not deliberately burn or tan to correct suspected deficiency.

1. What UV radiation does to skin

Ultraviolet radiation is invisible sunlight, distinct from the heat you feel. According to ARPANSA, UV is divided into three wavelength bands. Solar UVC is absorbed by the atmosphere; UVA and some UVB reach the ground.

Band	Wavelength	Practical significance
UVA	315–400 nm	Contributes to photoageing and skin cancer.
UVB	280–315 nm	A major cause of sunburn and direct DNA damage; contributes to skin cancer.
UVC	100–280 nm	Solar UVC does not normally reach ground level. Artificial sources are a separate exposure issue.

UV can damage DNA inside skin cells. Cells repair much of that damage, but unrepaired or incorrectly repaired changes can accumulate and contribute to cancer. Exposure can also cause premature skin ageing and harm the eyes. Visible redness is only one sign of injury: skin can sustain UV damage without a noticeable burn.

A UV-induced tan is a response to damage, not proof that skin has become safe in the sun. Repeated exposure adds to lifetime damage, so protection remains useful at every age.

Check the UV Index, not the temperature

The UV Index describes the intensity of sunburn-producing UV at ground level. Australian public advice generally calls for protection when it reaches 3 or higher. Cool weather and cloud do not reliably mean low UV. Check local protection times through SunSmart or ARPANSA’s Australian UV network. Reflected and scattered UV can still reach skin in shade.

2. Skin cancer types and Australia’s burden

Basal cell carcinoma and squamous cell carcinoma are often grouped as keratinocyte or non-melanoma skin cancers. Melanoma develops in pigment-producing melanocytes. Appearance alone cannot establish a diagnosis.

Type	Possible signs	Why assessment matters
Basal cell carcinoma (BCC)	A pearly or shiny bump, a persistent patch, or a sore that does not heal.	Usually grows locally but can damage surrounding tissue.
Squamous cell carcinoma (SCC)	A thickened scaly area, tender lump, or persistent ulcer.	Some SCCs can spread and become serious.
Melanoma	A new or changing spot, an unusual mole, or a growing nodule; it may lack dark pigment.	Can spread to other parts of the body; early assessment is important.

See Cancer Council’s skin cancer symptoms and risks and melanoma signs.

Cancer Council reports that at least two in three Australians will be diagnosed with skin cancer during their lifetime. That broad estimate includes keratinocyte cancers; it should not be confused with lifetime melanoma risk. Source: Cancer Council policy summary.

Measure	Australian figure	Data period
New melanomas diagnosed	15,034	2021 observed data
New melanomas	17,443	2025 estimate
Melanoma deaths	1,527	2023 observed data
Five-year relative survival	94%	People diagnosed in 2017–2021

Source: Cancer Australia, using AIHW data. These figures describe different periods. The 2025 projection is an estimate, not a final count. Relative survival compares survival in people with melanoma with the general population; it does not predict an individual’s outcome, which varies substantially by stage and other factors.

How much melanoma is attributable to UV?

IARC’s 2025 research estimated that more than 80% of cutaneous melanomas worldwide in 2022 were attributable to UV exposure, with particularly high attributable fractions in Australia and New Zealand. This is a population estimate based on comparison with a minimally exposed reference population, not a way to determine the cause of one person’s melanoma. Read the study. Different studies use different reference populations, so their attributable percentages should not be compared as if calculated identically.

3. Who is at higher risk?

Risk is higher with fair skin that burns easily, numerous or atypical moles, a personal history of skin cancer, a close family history of melanoma, and immunosuppression. Sunburn history and cumulative exposure also matter. Outdoor work adds repeated exposure and needs workplace protection. Multiple factors can combine; a person without obvious risk factors can still develop skin cancer.

In the Nurses’ Health Study II, 108,916 US women were followed in a cohort study. Reporting at least five blistering sunburns between ages 15 and 20 was associated with a melanoma relative risk of 1.80 compared with reporting none, and a relative risk of 1.68 for both BCC and SCC. These are associations, not proof that a particular burn causes cancer. The self-reported exposure history and study population limit generalisation. Read the 2014 study.

Darker skin generally carries lower UV-related skin-cancer risk, but risk is not zero. Check palms, soles and nails as well as sun-exposed skin; not all melanoma subtypes are primarily driven by UV. The 2024 Australian position statement recognises that protection and vitamin D needs differ across skin pigmentation and personal risk. Someone with a previous skin cancer or immunosuppression may need stronger protection regardless of skin colour.

4. Tanning, sunbeds and the base-tan myth

A base tan is not a reliable defence against further UV injury. Cosmetic oils without SPF do not provide sunscreen protection. Fake-tan colour also does not establish UV protection: continue using appropriate sun protection, and check any separate SPF claim and directions.

IARC classified UV-emitting tanning devices as carcinogenic to humans (Group 1) in 2009. That classification identifies a cancer hazard; sharing a category with another carcinogen does not mean their risks are equal. Source: IARC.

A 2012 meta-analysis of 27 studies associated ever using sunbeds with 20% higher melanoma risk. Its corrected estimate for first use before age 35 was 59% higher risk (relative risk 1.59; 95% CI 1.36–1.85). These observational estimates are not precise predictions for an individual. Read the analysis and its correction.

Commercial solariums were banned in most Australian jurisdictions from January 2015 and in Western Australia from January 2016; Cancer Council notes there are no commercial solariums in the Northern Territory. Its policy distinguishes commercial bans from private ownership and personal use. Neither legal status nor private access makes UV tanning safe. Source: Cancer Council.

5. Use the five sun-protection steps together

For most Australians, UV 3 or above is the routine trigger for combined protection. People at very high risk may need protection more consistently; people with deeply pigmented skin can need different advice. No single product covers every exposure situation.

Step	What to do	Important detail
Slip	Wear covering clothing.	Prioritise skin coverage and suitable fabric; UPF-rated garments help identify tested protection.
Slop	Use SPF50 or SPF50+, broad-spectrum, water-resistant sunscreen.	Apply enough and reapply; cover exposed skin that clothing does not protect.
Slap	Wear a broad-brimmed, suitable bucket or legionnaire-style hat.	Shade ears and neck as well as the face; baseball caps leave substantial skin exposed.
Seek	Use shade and plan activities around local UV.	Shade reduces exposure but does not eliminate scattered or reflected UV.
Slide	Wear close-fitting or wraparound sunglasses.	Check Australian-standard labelling and driving suitability; category 4 lenses are not for driving.

Sources: Cancer Council SunSmart advice, ARPANSA clothing guidance, hat guidance and sunglasses guidance. Clothing protects the skin it actually covers; stretching, wear, moisture and garment design can affect practical protection.

6. What sunscreen trials actually found

The Queensland Nambour trial provides important randomised evidence. It tested regular SPF15+ sunscreen use on specified exposed sites against discretionary use, not modern SPF50+ products against complete non-use. Its different outcomes need separate interpretation.

Study	Finding	Limit
Green et al., 1999: 1,621 adults; 4.5 years	SCC tumour rate ratio 0.61 (95% CI 0.46–0.81): about 39% fewer tumours at daily-application sites.	No significant reduction in first SCC diagnoses or BCC incidence. Tumour counts and people diagnosed are different outcomes.
Green et al., 2011: melanoma follow-up	11 melanomas versus 22; HR 0.50 (0.24–1.02), P=0.051. Invasive melanoma: 3 versus 11; HR 0.27 (0.08–0.97).	Few cases; the overall melanoma confidence interval included no effect. The invasive subgroup was encouraging but imprecise.
Hughes et al., 2013: 903 adults under 55	Relative odds of increased graded photoageing 0.76 (0.59–0.98) over 4.5 years.	A skin-ageing score, not proof of becoming 24% younger or reversing existing wrinkles.

Original reports: SCC/BCC trial · melanoma follow-up · photoageing trial. These findings support regular protection, while leaving uncertainty about the exact size of benefit for other populations, formulations and outcomes.

Choose, apply and store sunscreen correctly

Current Cancer Council guidance recommends SPF50 or SPF50+, broad-spectrum and water-resistant. SPF is a standardised sunburn-protection measure, not a safe-time multiplier. Broad-spectrum labelling matters because SPF alone does not describe the full UVA protection. SPF values from different products do not add together.

Read the directions and apply to clean, dry exposed skin about 20 minutes before going outdoors.
For an average adult’s full body, allow about 35 mL: one teaspoon for the face/neck/ears together, one for each arm, one for each leg, one for the front and one for the back.
Reapply every two hours and immediately after swimming, sweating or towel-drying. Water resistance does not mean all-day protection.
Check the expiry date and storage instructions. Many labels specify below 30°C; avoid leaving sunscreen in a hot car.
Choose a formulation you can apply generously and consistently. Stop a product that causes a reaction and seek advice about alternatives.

Source: Cancer Council application and storage guidance. For therapeutic sunscreens, look for the relevant AUST number and check current TGA advice. A printed standards reference is not a substitute for checking the exact product and any regulator notice.

7. Sunscreen safety: what is known and still being studied

Mineral nanoparticles: the TGA’s evidence review found that zinc oxide and titanium dioxide nanoparticles generally remain on the surface or outer skin layers, with little penetration. Its current guidance describes them as safe when used as directed. That evidence should not be turned into a claim that no material can ever be absorbed under any circumstance.

Chemical-filter absorption: FDA research detected systemic absorption of some filters. Crossing a threshold used to request additional safety data is not the same as crossing a demonstrated toxicity threshold. Absorption studies do not by themselves show that ordinary use causes cancer, nor establish that every ingredient is equally well studied.

Ongoing regulation: the TGA continues to review individual ingredients and propose safeguards where needed. Follow current product-specific safety alerts and recall advice. A review of one ingredient does not show that all sunscreens are unsafe. Use other protection measures as well, and ask a pharmacist or doctor about reactions or a suitable alternative.

Sources: TGA sunscreen ingredients and reviews and FDA explanation of absorption and safety data. For more context, read Tanrub’s sunscreen safety article.

8. Vitamin D: balance needs without deliberate UV damage

UV exposure supports vitamin D production, but the balance of benefit and harm differs with pigmentation, location, season, clothing, age and medical history. The 2024 Australian position statement identifies different risk groups. Sun protection is essential for people at very high skin-cancer risk; people at intermediate risk should prioritise protection while maintaining appropriate outdoor activity. Those with deeply pigmented skin generally have much lower skin-cancer risk and higher deficiency risk, and may not need routine protection except during extended exposure. Individual risk factors still matter.

Newer evidence also needs acknowledgement. The 2025 Sun D trial found that daily SPF50+ users were more likely to develop vitamin D deficiency than discretionary users over one year. Cancer Council’s response was to continue combined sun protection while managing vitamin D appropriately, not to abandon sunscreen. Read Cancer Council’s response and linked trial.

Do not use deliberate tanning or sunburn as treatment for suspected deficiency. Ask a clinician whether your circumstances warrant testing, dietary changes or supplementation; a blood test is not a routine prerequisite for every healthy person. There is no single number of sun-exposure minutes that is suitable for everyone.

9. Babies and children need extra care

Keep babies under 12 months away from direct sunlight as much as possible when UV is 3 or above. Prioritise shade, covering clothing and an appropriate hat. Ensure prams remain ventilated: do not drape a blanket over a pram in a way that traps heat or restricts airflow. Shade does not remove all reflected UV.

Widespread sunscreen use under six months is generally not recommended because babies have sensitive skin. Ask a healthcare professional about unavoidable exposure and product suitability. For older babies, sunscreen supplements physical protection rather than replacing it. Follow product directions, test a new product on a small area, and stop if a reaction occurs. Direct sunlight is not an appropriate home treatment for newborn jaundice.

Older children benefit from the same combination of measures and from adults modelling consistent protection. Choose properly labelled sunglasses rather than toys sold as fashion accessories. Source: Cancer Council babies guidance.

10. Notice changes and seek assessment promptly

Get to know your skin, including areas that rarely see the sun. A partner or mirror can help with your back and scalp. Look for a new lesion, a spot that changes, an unusual lesion that differs from your other moles, or a sore that persists, bleeds or does not heal.

ABCDE prompt	Change to notice
Asymmetry	One half differs from the other.
Border	Irregular, notched or poorly defined edges.
Colour	Uneven colour or several shades.
Diameter	A larger spot can be concerning, but melanomas can be smaller than 6 mm.
Evolving	Change in size, shape, colour, symptoms or elevation.

The checklist is not a diagnostic test. Some melanomas are pink or red, small, or relatively symmetrical. An elevated, firm and growing lesion also warrants assessment. Do not wait for every warning sign to appear. Source: American Cancer Society signs and symptoms; see also Cancer Council’s ABCD/EFG guidance.

Professional checks are based on risk

Assessment of a suspicious spot is different from screening a person without symptoms. Cancer Council does not recommend population-wide melanoma screening because high-level evidence of reduced mortality is lacking. It does support surveillance for people at higher risk; a GP or dermatologist can advise on an appropriate schedule, dermoscopy and photography. Do not delay seeing a doctor about a concerning change while waiting for a scheduled check. Source: Cancer Council early-detection position statement.

Common myths and practical answers

Myth	Evidence-based answer
A cool day is a low-UV day.	Temperature is an unreliable guide; check local UV.
A base tan or fake tan protects me.	Colour does not replace effective protection.
One morning application lasts all day.	Reapply as directed, including every two hours outdoors and after swimming or sweating.
Higher SPF gives permission to stay out longer.	SPF is not a safe exposure-time multiplier.
Darker skin cannot develop cancer.	Risk is lower, not zero; concerning changes still need assessment.
Absorption proves sunscreen is dangerous.	Absorption prompts safety investigation; it does not alone demonstrate harm.
Every healthy person needs the same annual skin check.	Professional surveillance should reflect personal risk; symptoms need prompt assessment.

Sources, scope and further reading

Direct references appear beside the relevant claims above. Priority sources are Australian public-health agencies, regulators and original study reports or indexed abstracts. This is a focused editorial overview, not a systematic review or individual medical assessment. Estimates, guidance and regulator notices can change.

Sun Safety and Skin Cancer: What the Evidence Shows